160 related articles for article (PubMed ID: 36906469)
1. Insulin Therapy in Small Animals, Part 1: General Principles.
Fleeman L; Gilor C
Vet Clin North Am Small Anim Pract; 2023 May; 53(3):615-633. PubMed ID: 36906469
[TBL] [Abstract][Full Text] [Related]
2. One hundred years of insulin: Is it time for smart?
Gilor C; Fleeman LM
J Small Anim Pract; 2022 Sep; 63(9):645-660. PubMed ID: 35560042
[TBL] [Abstract][Full Text] [Related]
3. Insulin Therapy in Small Animals, Part 3: Dogs.
Fleeman L; Gilor C
Vet Clin North Am Small Anim Pract; 2023 May; 53(3):645-656. PubMed ID: 36906466
[TBL] [Abstract][Full Text] [Related]
4. Insulin Therapy in Small Animals, Part 2: Cats.
Fleeman L; Gilor C
Vet Clin North Am Small Anim Pract; 2023 May; 53(3):635-644. PubMed ID: 36906468
[TBL] [Abstract][Full Text] [Related]
5. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
6. Use of glargine and lente insulins in cats with diabetes mellitus.
Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
[TBL] [Abstract][Full Text] [Related]
7. Synthetic insulin analogs and their use in dogs and cats.
Gilor C; Graves TK
Vet Clin North Am Small Anim Pract; 2010 Mar; 40(2):297-307. PubMed ID: 20219490
[TBL] [Abstract][Full Text] [Related]
8. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
[TBL] [Abstract][Full Text] [Related]
9. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
10. Day-to-day variability of porcine lente, insulin glargine 300 U/mL and insulin degludec in diabetic dogs.
Miller M; Pires J; Crakes K; Greathouse R; Quach N; Gilor C
J Vet Intern Med; 2021 Sep; 35(5):2131-2139. PubMed ID: 34241910
[TBL] [Abstract][Full Text] [Related]
11. Update on drugs used to treat endocrine diseases in small animals.
Behrend EN
Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1087-105, vii. PubMed ID: 16984828
[TBL] [Abstract][Full Text] [Related]
12. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
[TBL] [Abstract][Full Text] [Related]
13. Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes.
Heise T; Mathieu C
Diabetes Obes Metab; 2017 Jan; 19(1):3-12. PubMed ID: 27593206
[TBL] [Abstract][Full Text] [Related]
14. A patient centred approach to basal insulin choice for the management of type 2 diabetes mellitus.
Kalra S; Gupta Y
J Pak Med Assoc; 2016 Mar; 66(3):360-1. PubMed ID: 26968297
[TBL] [Abstract][Full Text] [Related]
15. Editorial: glargine, a new long-acting insulin analog for diabetic cats.
Rand J
J Vet Intern Med; 2006; 20(2):219-20. PubMed ID: 16594574
[No Abstract] [Full Text] [Related]
16. Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial.
Evans M; Moes RGJ; Pedersen KS; Gundgaard J; Pieber TR
Adv Ther; 2020 May; 37(5):2413-2426. PubMed ID: 32306247
[TBL] [Abstract][Full Text] [Related]
17. Basal insulin analogues in the management of diabetes mellitus: What progress have we made?
Owens DR; Matfin G; Monnier L
Diabetes Metab Res Rev; 2014 Feb; 30(2):104-19. PubMed ID: 24026961
[TBL] [Abstract][Full Text] [Related]
18. Synthetic long-acting insulin analogs for the management of type 1 diabetes: an update.
Pedersen-Bjergaard U; Fabricius TW; Thorsteinsson B
Expert Opin Pharmacother; 2021 Nov; 22(16):2251-2259. PubMed ID: 34467826
[TBL] [Abstract][Full Text] [Related]
19. Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4.
Betônico CC; Titan SMO; Lira A; Pelaes TS; Correa-Giannella MLC; Nery M; Queiroz M
Clin Ther; 2019 Oct; 41(10):2008-2020.e3. PubMed ID: 31383366
[TBL] [Abstract][Full Text] [Related]
20. Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats.
Marshall RD; Rand JS; Morton JM
J Vet Pharmacol Ther; 2008 Jun; 31(3):205-12. PubMed ID: 18471141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
